PREDICTIVE ONCOLOGY INC (POAI)
US74039M3097 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.42M 13.60% | 1.51M 6.34% | 1.78M 17.89% | 1.422M -20.12% | 9.52M 569.48% | 15.756M 65.50% | |
| EBITDA YoY % growth | -12.13M -5.75% | -13.95M -15.00% | -13.182M 5.51% | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.47M -7.85% | -15.26M -13.29% | -13.921M 8.77% | -11.601M 16.66% | -1.895M 83.66% | 1.58M 183.37% | |
| Operating Margin | -948.59% | -1,010.60% | -782.06% | -815.86% | -19.91% | 10.03% | |
| EPS YoY % growth | -0.37 98.77% | N/A 14.54% | N/A 61.29% | -2.12 -1,633.33% | -0.13 93.75% | 0.08 161.54% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.26 | -0.09 | -0.09 | -0.09 80.88% | 0.06 124.00% |
| Revenue Q2Q % growth | 357K 6.56% | 1.53M 264.59% | 1.53M 448.94% | 1.53M 342.20% | 5.1M 1,328.57% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.667M 52.46% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.48 | -0.33 | -0.15 | -47.06% |
| Q4 2022 Q2Q % growth | 52.92% | -0.06 | % | |
| Q3 2022 Q2Q % growth | -0.05 37.50% | -0.01 | -0.04 | -390.20% |
| Q2 2022 Q2Q % growth | -0.15 -200.00% | -0.03 | -0.12 | -390.20% |
| Q1 2022 Q2Q % growth | -1.00 -809.09% | -0.82 | -0.18 | -22.55% |
| Q4 2021 Q2Q % growth | -0.13 81.43% | -0.03 | -0.10 | -409.80% |
| Q3 2021 Q2Q % growth | -0.08 | -0.05 | -0.03 | -56.86% |
| Q2 2021 Q2Q % growth | -0.05 | -0.08 | 0.03 | 34.64% |
| Q1 2021 Q2Q % growth | -0.11 | -0.09 | -0.02 | -19.83% |
| Q4 2020 Q2Q % growth | -0.70 | -0.18 | -0.52 | -281.26% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 346K -51.94% | 510K | -164K | -32.16% |
| Q2 2024 Q2Q % growth | 278.72K -43.12% | % | ||
| Q1 2024 Q2Q % growth | 419.65K 74.85% | % | ||
| Q4 2023 Q2Q % growth | 335.03K -6.94% | % | ||
| Q3 2023 Q2Q % growth | 720K 56.52% | % | ||
| Q2 2023 Q2Q % growth | 490K 32.43% | % | ||
| Q1 2023 Q2Q % growth | 240K -22.58% | % | ||
| Q4 2022 Q2Q % growth | 360K -25.00% | 510K | -150K | -29.41% |
| Q3 2022 Q2Q % growth | 460K 48.39% | 4.08M | -3.62M | -88.73% |
| Q2 2022 Q2Q % growth | 370K 5.71% | 2.04M | -1.67M | -81.86% |
| Q1 2022 Q2Q % growth | 310K 10.71% | 1.02M | -710K | -69.61% |
| Q4 2021 Q2Q % growth | 480K 65.52% | 2.55M | -2.07M | -81.18% |
| Q3 2021 Q2Q % growth | 310K -35.42% | 1.224M | -914K | -74.67% |
| Q2 2021 Q2Q % growth | 350K 94.44% | 612K | -262K | -42.81% |
| Q1 2021 Q2Q % growth | 280K -3.45% | 357M | -356.72M | -99.92% |
| Q4 2020 Q2Q % growth | 290K -17.14% | 357M | -356.71M | -99.92% |
| Q3 2020 Q2Q % growth | 480K -7.69% | % | ||
| Q2 2020 Q2Q % growth | 180K -37.93% | % | ||
| Q1 2020 Q2Q % growth | 290K 11.54% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | 0% | -2.46% |
| Revenue | 0% | N/A | 0% | -9.94% |